Altimmune

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Altimmune and other ETFs, options, and stocks.

About ALT

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH.

CEO

Vipin K. Garg

CEOVipin K. Garg

Employees

Employees59

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1997

Founded1997

Employees

Employees59

ALT Key Statistics

Market cap

333.17M

Market cap333.17M

Price-Earnings ratio

-3.18

Price-Earnings ratio-3.18

Dividend yield

—

Dividend yield—

Average volume

3.10M

Average volume3.10M

High today

$3.77

High today$3.77

Low today

$3.67

Low today$3.67

Open price

$3.74

Open price$3.74

Volume

109.84K

Volume109.84K

52 Week high

$11.16

52 Week high$11.16

52 Week low

$2.90

52 Week low$2.90

ALT News

TipRanks 7d

Altimmune rallies after FDA accepts liver stiffness as MASH endpoint

The Food and Drug Administration’s Center for Drug Evaluation and Research, Office of New Drugs said it has accepted a letter of intent for the qualification of...

Analyst ratings

80%

of 10 ratings

Buy

80%

Hold

10%

Sell

10%

People also own

Based on the portfolios of people who own ALT. This list is generated using Robinhood data, and it’s not a recommendation.